Health Care & Life Sciences » Pharmaceuticals | Rui Kang Pharmaceutical Group Investments Ltd.

Rui Kang Pharmaceutical Group Investments Ltd.

Rui Kang Pharmaceutical Group Investments Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.07
Market Cap
HKD1.25 B
Shares Outstanding
968.66 M
Public Float
277.55 M

Profile

Address
Suites 1904-05A, 19/F, Sino Plaza
Hong Kong
Hong Kong
Employees -
Website http://www.cbshhk.com
Updated 07/08/2019
China Biotech Services Holdings Ltd. is an investment company, which engages in the provision of medical laboratory testing, and health check services. It operates through the following segments: Pharmaceutical Products, Medical and Health Related Services, Securities, and Others. The Pharmaceutical Products segment manufactures, researches, develops, sells, and distributes health related and pharmaceutical products.

Financials

View All
Created with Highcharts 5.0.14Rui Kang Pharmaceutical Group Investments Ltd.Net Income. Fiscal year is January-December. All values HKD Thousands.14 86714 86774 85474 85454 16054 16085 67785 67763 02263 02264 25064 250201220142015201620172018020k40k60k80k100k
Created with Highcharts 5.0.14Rui Kang Pharmaceutical Group Investments Ltd.Sales/Revenue. Fiscal year is January-December. All values HKD Thousands.61 26761 26770 11070 11034 12734 12786 56586 565105 135105 13570 30470 304201220142015201620172018025k50k75k100k125k

Xiao Lin Liu
Chairman
Pak Hou Leung
Executive Director & Compliance Officer